BMY vs DXCM
Bristol Myers Squibb vs Dexcom — AI-powered side-by-side comparison
| Metric | BMY | DXCM |
|---|---|---|
| AI Score | 57 | 64 |
| Price | $60.52 | $78.01 |
| P/E Ratio | 17.00× | 32.49× |
| ROE | 0.4% | 0.3% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.6% |
| Debt / Equity | 2.22× | 0.47× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 57.1 | 49.2 |
| Beta | 0.235 | 1.453 |
| Expected Upside | +2.6% | +4.5% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
DXCM Full Analysis